Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mark L. Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre & Louis B. Chaykin. (2019) Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. Current Medical Research and Opinion 35:9, pages 1623-1629.
Read now
Read now
Séverine Vermeire, François D’heygere, Antoine Nakad, Denis Franchimont, Fernand Fontaine, Edouard Louis, Philippe Van Hootegem, Olivier Dewit, Guy Lambrecht, Beatrijs Strubbe & Filip Baert. (2018) Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Preference and Adherence 12, pages 1193-1202.
Read now
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Read now
Timothy S. Bailey & Jenine Y. Stone. (2017) A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice. Expert Opinion on Drug Delivery 14:5, pages 697-703.
Read now
Read now
Christine Y Lu, Isabel Cristina M Emmerick, Peter Stephens, Dennis Ross-Degnan & Anita K Wagner. (2015) Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. Journal of Pharmaceutical Policy and Practice 8:1.
Read now
Read now
Andreas Pfützner, Thomas Forst, Marcus Niemeyer & Timothy Bailey. (2014) Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals. Expert Opinion on Drug Delivery 11:9, pages 1381-1389.
Read now
Read now
Jiajia Ji & Qingqing Lou. (2014) Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010. Current Medical Research and Opinion 30:6, pages 1087-1093.
Read now
Read now
Dorte Götzche, Bo Ølgaard Rasmussen, Michael Torben Pedersen, Thomas Sparre, Ditlef Bucher & Marcus Niemeyer. (2013) Injection force and dose accuracy of FlexTouch for the delivery of a new basal insulin. Expert Opinion on Drug Delivery 10:12, pages 1613-1619.
Read now
Read now
Articles from other publishers (20)
Pritam Ghosh & Priyabrata Banerjee. (2023) Drug delivery using biocompatible covalent organic frameworks (COFs) towards a therapeutic approach. Chemical Communications 59:84, pages 12527-12547.
Crossref
Crossref
Jothydev Kesavadev, Gopika Krishnan & Nelena Benny. 2023. The Diabetes Textbook. The Diabetes Textbook
1141
1158
.
Małgorzata Masierek, Katarzyna Nabrdalik, Oliwia Janota, Hanna Kwiendacz, Maksymilian Macherski & Janusz Gumprecht. (2022) The Review of Insulin Pens—Past, Present, and Look to the Future. Frontiers in Endocrinology 13.
Crossref
Crossref
Sreenivasa Murthy, Pankaj Aneja, Arthur Joseph Asirvatham, Lise Lotte N. Husemoen, Nicolai A. Rhee & Jothydev Kesavadev. (2021) Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market. PharmacoEconomics - Open 5:2, pages 261-273.
Crossref
Crossref
Farah Benyettou, Nawel Kaddour, Thirumurugan Prakasam, Gobinda Das, Sudhir Kumar Sharma, Sneha Ann Thomas, Fadia Bekhti-Sari, Jamie Whelan, Mohammed A. Alkhalifah, Mostafa Khair, Hassan Traboulsi, Renu Pasricha, Ramesh Jagannathan, Nassima Mokhtari-Soulimane, Felipe Gándara & Ali Trabolsi. (2021)
In vivo
oral insulin delivery
via
covalent organic frameworks
. Chemical Science 12:17, pages 6037-6047.
Crossref
Crossref
Eric Zijlstra, Hans‐Veit Coester, Tim Heise, Leona Plum‐Mörschel, Ole Rasmussen, Tord Rikte, Line Kynemund Pedersen, Marianne Qvist & Thomas Sparre. (2018) Injecting without pressing a button: An exploratory study of a shield‐triggered injection mechanism. Diabetes, Obesity and Metabolism 20:5, pages 1140-1147.
Crossref
Crossref
Christopher M. Kappes, James R. Kershner, Tina M. Morwick & Sheila M. Corrigan. (2017) Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen. Journal of Diabetes Science and Technology 12:2, pages 364-372.
Crossref
Crossref
L P Ainscough, J L Ford, C W Morecroft, M Peak, M A Turner, A J Nunn & M Roberts. (2018) Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review. European Journal of Hospital Pharmacy 25:2, pages 66-71.
Crossref
Crossref
Jenine Y Stone, Nalani Haviland & Timothy S Bailey. (2018) Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes. Therapeutic Delivery 9:2, pages 77-87.
Crossref
Crossref
Niels GudiksenThibaud HofstätterBirgitte B. RønnThomas Sparre. (2017) FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Diabetes Technology & Therapeutics 19:10, pages 603-607.
Crossref
Crossref
Andreas Pfützner. (2017) Patients’ Preferences for Insulin Injection Devices. Journal of Diabetes Science and Technology 11:2, pages 270-271.
Crossref
Crossref
Luigi F. MeneghiniJacqueline Nicole McNulty. (2017) Role of Devices in Insulin Delivery. Diabetes Technology & Therapeutics 19:2, pages 76-78.
Crossref
Crossref
Chelsea Smallwood, Danièle Lamarche & Annie Chevrier. (2017) Examining Factors That Impact Inpatient Management of Diabetes and the Role of Insulin Pen Devices. Canadian Journal of Diabetes 41:1, pages 102-107.
Crossref
Crossref
Rami Tarabay, Rola El Rassi, Abeer Dakik, Alain Harb, Rami A. Ballout, Batoul Diab, Selma Khamassi & Elie A. Akl. (2016) Knowledge, attitudes, beliefs, values, preferences, and feasibility in relation to the use of injection safety devices in healthcare settings: a systematic review. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Barbara Freeland & Margo S. Farber. (2016) A Review of Insulin for the Treatment of Diabetes Mellitus. Home Healthcare Now 34:8, pages 416-423.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Susan LaRue & Jaret Malloy. (2015) Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes. Journal of Diabetes Science and Technology 9:4, pages 815-821.
Crossref
Crossref
Rey T. Chern, Jeffrey C. Givand, Robin Hwang & Thomas J. Nikolai. 2015. Quality by Design for Biopharmaceutical Drug Product Development. Quality by Design for Biopharmaceutical Drug Product Development
403
435
.
Angela O. ShogbonDao NgoBobby JacobLaura P. KimbleGina Ryan. (2014) Nurses' Perceptions and Satisfaction with the Use of Insulin Pen Devices Compared with Insulin Vial and Syringes in an Inpatient Setting. Diabetes Technology & Therapeutics 16:11, pages 742-746.
Crossref
Crossref
Kimberly A. Driscoll & Deborah Young-Hyman. (2014) Use of Technology When Assessing Adherence to Diabetes Self-Management Behaviors. Current Diabetes Reports 14:9.
Crossref
Crossref